Clostridium difficile, which causes pseudomembranous colitis in patients undergoing antibiotic therapy, is an important nosocomial pathogen (8) . The disease results from the tissue-damaging toxins (toxin A and toxin B) produced by toxigenic strains of the organism. A number of different tests (tissue culturing, enzyme immunoassay, and latex agglutination) have been developed as aids in the diagnosis of the disease. The tissue culture test, which has been in use for over 10 years, and the enzyme immunoassay, which is currently being evaluated, detect the toxins produced by the organism. The latex agglutination tests marketed by Becton Dickinson Microbiology Systems (Culturette CDT) and Meridian Diagnostics, Inc. (Meritec-C. difficile), on the other hand, detect a nontoxic protein (Mr 43,000, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE]) produced by C. difficile and do not distinguish between toxigenic and nontoxigenic strains (9) . The gene encoding the protein was originally cloned in our laboratory to demonstrate the absence of toxic activities associated with the latex test-reactive protein and to show that it is distinct from the toxins of C. difficile (7) . Strains of C. sporogenes and Peptostreptococcus anaerobius produce a similar protein.
During the course of our studies of the latex test-reactive protein, we noted that the protein possesses several properties that may yield useful information about clostridial proteins in general. First, the latex test-reactive protein elicits high levels of precipitating antibodies in experimental animals, indicating that it may be useful as a carrier molecule for antibody production. Second, the recombinant protein is produced in high amounts (>10 Fxg/ml) when expressed in Escherichia coli, unlike other clostridial proteins that we have examined (10) ; thus, the results of studies of this protein may indicate why some recombinant clostridial proteins are expressed much better than others. On the basis of these observations, we continued our studies of the protein in an effort to identify its function. Our experimental approach consisted of (i) sequencing the gene encoding the protein, (ii) identifying the function of the protein by comparing the deduced amino acid sequence with the sequences of other proteins, and (iii) confirming the identified activity by enzymatic analysis.
Cloning and sequencing were done with the DraI fragment (pCD5A) encoding the latex test-reactive protein (7) by * Corresponding author. previously described procedures (3, 11) . Expression of the recombinant protein was accomplished with an exonucleasedigested portion of the fragment. The Sequence Analysis Software Package developed by the Genetics Computer Group at the University of Wisconsin was used for sequence analysis. The National Biomedical Research Foundation Protein Sequence Data Base was used for analysis of the deduced amino acid sequence.
For N-terminal sequencing, flasks containing 500 ml of Luria-Bertani medium were inoculated with E. coli JM109/ pCD5A carrying the gene insert and incubated at 37°C with shaking (200 cycles per min on a gyratory shaker) for 48 h. The cells were collected by centrifugation, suspended in 20 ml of 0.05 M Tris-HCl buffer (pH 7.5), and lysed with a French pressure cell. The debris was removed by centrifugation, and the lysate containing the recombinant protein was passed through a 0.45-,um-pore-size membrane and stored at 4°C. The recombinant protein was purified by gel filtration chromatography on Ultrogel AcA22. Fractions containing the recombinant protein were identified by fused rocket immunoelectrophoresis (1) with rabbit antiserum against the latex test-reactive antigen (7), and the N-terminal sequence was determined by previously described methods (3, 12) .
Glutamate dehydrogenase activity was measured at 340 nm with reaction mixtures containing 1 ml of 300 mM potassium phosphate buffer (pH 8), 0.5 ml of 300 mM glutamic acid neutralized to pH 7.5, 0.45 ml of 1 mM NAD, 1 ml of deionized water, and 0.05 ml of test sample. Bovine liver L-glutamate dehydrogenase (Sigma Chemical Co.) served as the positive control. The protein concentration was determined by use of Coomassie protein assay reagent with bovine serum albumin as the standard (Pierce, Rockford, 111.).
In our previous cloning studies of the latex test-reactive protein (7) (Fig. 2) . On the basis of this finding, we analyzed the recombinant protein for glutamate dehydrogenase activity (Fig. 3) regulatory mechanisms. These enzymes are highly conserved and exhibit an extremely low rate of point mutations relative to many other proteins (2) . The glutamate dehydrogenase of C. difficile, which has been of interest because of its usefulness as a diagnostic marker for the presence of the organism in fecal specimens, also is highly conserved. Glutamate dehydrogenases from other clostridia, including C. butyricum, C. kluyveri, and C. symbiosum, have been studied, but their sequences have not been determined (6, 19) .
Nucleotide sequence accession number. The GenBank accession number for the sequence reported here is M65250. (9) 
